Table 4.
Radiological changes between baseline and follow-up imaging tests in total shunt diameter and total shunt area in cured and non-cured patients.
| Total shunt diameter, mm, mean (SD) | p value | TSA, mm2, mean (SD) | p value | |
|---|---|---|---|---|
| Cured patients (n = 82) | ||||
| SPSS inclusion | 8.6 (8.8) | 0.0261 | 102.5 (252.0) | 0.5426 |
| SPSS follow-up |
11.0 (7.7) |
119.8 (142.1) |
||
| Non-cured patients (n = 76) | ||||
| SPSS inclusion | 7.9 (7.1) | <0.001 | 74.3 (88.7) | <0.001 |
| SPSS follow-up | 12.1 (7.5) | 122.1 (116.4) | ||
Cured patients are defined as those who are abstinent for alcohol-related cirrhosis and/or those who have received successful HCV therapy for HCV-related cirrhosis. Non-cured patients are defined as patients with alcohol-related cirrhosis without abstinence and/or HCV-related cirrhosis without treatment or without sustained viral response. A minimum diameter of >5 mm was considered to provide accurate SPSS size. Variables are reported as mean (SD). Level of significance: p <0.05 (paired t test).
SPSS, spontaneous portosystemic shunts; TSA, total shunt area.